Omeprazole and talampanel as two examples of retrometabolic drug design

Pharmazie

Volumn 59, Issue 5, 2004, Pages 365-366

  Andrási, Ferenc ^a   Berzsenyi, P ^a   Farkas, L ^a   Korosi J ^a   Hamori T ^a   Botka, P ^a   Ling, I ^a   Lang T ^a  

^a TEVA PHARMACEUTICALS   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; OMEPRAZOLE; TALAMPANEL;

ANTICONVULSANT ACTIVITY; CONFERENCE PAPER; DRUG DESIGN; DRUG SYNTHESIS; MUSCLE RELAXATION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTICONVULSANTS; BENZODIAZEPINES; DRUG DESIGN; ENZYME INHIBITORS; H(+)-K(+)-EXCHANGING ATPASE; INDICATORS AND REAGENTS; OMEPRAZOLE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2642533755     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Andrási F (2001) Search for antiulcer agents at IDR. Pharmazie 56: S 31-33.
2. Andrási F, Berzsenyi P, Tarnawa I, Farkas S, Kõrösi J, Botka P, Láng T (1988) GYKI 52466: A new 2,3-benzodiazepine central muscle relaxant. Eur. J. Neuroscience S-1: 74. And 547 other publications on the BioMedNet.
3. Andrási F, Borsy J, Farkas L (1973) Structure-activity relationship among antigastrin compounds. Acta Pharm Hung 43: 116-120.
4. th ed. vol. 2., New York, p. 533-608.
5. Chappell AS, Sander JW, Brodie MJ, Chadwick D, Lledo A, Zhang D, Bjerke J, Kiesler GM, Arroyo S (2002) A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology 58: 1680-1682.
6. 14C labelled 2-PTA, a specific antigastrin agent. Acta Physiol Hung 39: 158.
7. Farkas L, Fuchs O, Andrási F (1973) Synthesis of new antiulcer compounds. Acta Pharm Hung 43: 111-115.
8. Hideg K, Hankovszky HO, Méhes G, Váczi L, Ördögh F (1969) Pyridylalkyl-substituted benzimidazoles. C.A. 71, 91479t. HU Patent 156,129.